Index of reports
> All Cases (2254)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vincristine all cases. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 2254 Next >>
Possible Vincristine side effects in 49 year old male
Reported by a physician from Norway on 2012-08-27
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Possible Vincristine side effects in 49 year old male
Reported by a physician from Norway on 2012-08-27
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: 10000 iu, day 8 (2 escalated cycles)
Indication: Hodgkin's Disease
Bleomycin Sulfate
Dosage: 10000 iu, day 8 (4 standard cycles)
Cyclophosphamide
Dosage: 650 mg/m2, day 1 (4 standard cycles)
Cyclophosphamide
Dosage: 1250 mg/m2, day 1 (2 escalated cycles)
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 25 mg/m2, day 1 (4 standard cycles)
Doxorubicin HCL
Dosage: 35 mg/m2, day 1 (2 escalated cycles)
Indication: Hodgkin's Disease
Etoposide
Dosage: 100 mg/m2, day 1-3 (4 standard cycles)
Etoposide
Dosage: 200 mg/m2, day 1-3 (2 escalated cycles)
Indication: Hodgkin's Disease
Prednisolone
Dosage: 40 mg/m2, day 1-14 (4 standard cycles)
Administration route: Oral
Prednisolone
Dosage: 40 mg/m2, day 1-14 (2 escalated cycles)
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 100 mg/m2, day 1-7 (2 escalated cycles)
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 100 mg/m2, day 1-7 (4 standard cycles)
Administration route: Oral
Vincristine
Dosage: 1.4 mg/m2, day 8 (2 escalated cycles)
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2, day 8 (4 standard cycles)
Possible Vincristine side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-27
Patient: male
Reactions: Dystonia, Encephalopathy, Parkinsonism
Drug(s) suspected as cause:
Cisplatin
Cyclophosphamide
Etoposide
Ifosfamide
Vincristine
Possible Vincristine side effects in 47 year old male
Reported by a physician from France on 2012-08-27
Patient: 47 year old male
Reactions: Respiratory Tract Infection Bacterial, Epstein-Barr Virus Associated Lymphoma, Congestive Cardiomyopathy, Systolic Dysfunction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-06-08
Doxorubicin HCL
Start date: 2012-06-11
End date: 2012-07-10
Mabthera
Start date: 2012-06-11
Nexium
Administration route: Oral
Prednisolone
Administration route: Oral
Start date: 2012-06-08
Vincristine
Start date: 2012-06-08
Other drugs received by patient: Previscan; Methotrexate Sodium; Potassium Chloride; Kineret; Kineret; Kineret; Cacit D3; Aspirin; Prednisone TAB; Acetaminophen; Acetaminophen W / Codeine; Alendronate Sodium / Cholecalciferol
Possible Vincristine side effects in male
Reported by a physician from France on 2012-08-27
Patient: male
Reactions: Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Burkitt's Lymphoma
Start date: 2012-05-21
End date: 2012-05-23
Doxorubicin Hydrochloride
Indication: Burkitt's Lymphoma
Start date: 2012-05-21
End date: 2012-05-21
Levoleucovorin Calcium
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-21
End date: 2012-05-25
Mabthera
Indication: Burkitt's Lymphoma
Start date: 2012-05-19
End date: 2012-05-19
Methotrexate Disodium
Indication: Burkitt's Lymphoma
Start date: 2012-05-20
Methotrexate Disodium
Start date: 2012-05-25
Prednisone TAB
Administration route: Oral
Indication: Burkitt's Lymphoma
Start date: 2012-05-20
End date: 2012-05-24
Vincristine
Start date: 2012-05-25
Vincristine
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-20
Other drugs received by patient: Cytarabine; Calciparine; Ondansetron Hydrochloride; Allopurinol; Valaciclovir HCL; Nexium; Lyrica; Bactrim DS; Emend
Possible Vincristine side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: Off Label Use, Gastrointestinal Toxicity, Neutropenia, Infection
Drug(s) suspected as cause:
Carboplatin
Dosage: 6 courses in high risk
Indication: Retinoblastoma
Cyclophosphamide
Indication: Retinoblastoma
Doxorubicin Hydrochloride
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Etoposide
Indication: Retinoblastoma
Vincristine
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Other drugs received by patient: Neupogen
Possible Vincristine side effects in 10 year old male
Reported by a physician from United States on 2012-08-27
Patient: 10 year old male, weighing 76.1 kg (167.4 pounds)
Reactions: Hypersensitivity, Hyperglycaemia, Peripheral Motor Neuropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Cytarabine
Dosage: 75mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Mercaptopurine
Dosage: 60mgm2 cyclic
Administration route: Oral
Indication: T-Cell Type Acute Leukaemia
Methotrexate
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-06
Nelarabine
Dosage: 650mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-05-22
PEG-Asparaginase
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-13
Vincristine
Dosage: 1.5mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-13
Other drugs received by patient: Radiation
Possible Vincristine side effects in 79 year old female
Reported by a physician from Germany on 2012-08-27
Patient: 79 year old female
Reactions: Sciatica, Lumbar Vertebral Fracture
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Mabthera
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Prednisone
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Vincristine
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Possible Vincristine side effects in male
Reported by a physician from Netherlands on 2012-08-27
Patient: male, weighing 95.0 kg (209.0 pounds)
Reactions: Cranial Nerve Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: third maintenance cycle
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-06
Cyclophosphamide
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: third maintenance cycle
Start date: 2010-09-06
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Neupogen
Dosage: third maintenance cycle
Start date: 2010-09-07
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Dosage: third maintenance cycle
Administration route: Oral
Start date: 2010-09-06
Rituximab
Dosage: third maintenance cycle
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-06
Rituximab
Start date: 2010-11-29
End date: 2011-03-21
Vincristine
Dosage: third maintenance cycle
Start date: 2010-09-06
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Vincristine side effects in female
Reported by a physician from Switzerland on 2012-08-27
Patient: female, weighing 87.7 kg (192.9 pounds)
Reactions: Cholecystitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Prednisolone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-12
Rituximab
Dosage: concentration 1/mg/ml
Start date: 2011-11-11
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Other drugs received by patient: Pantoprazole; Exforge HCT; Dipyrone INJ; Bisoprolol Fumarate; Domperidon; Bactrim DS; Acetaminophen; Metformin Hydrochloride
Possible Vincristine side effects in 43 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-27
Patient: 43 year old female
Reactions: Off Label Use, Blindness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Etoposide
Ifosfamide
Vincristine
Possible Vincristine side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male
Reactions: Febrile Neutropenia, Skin Infection, Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Doxorubicin Hydrochloride
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Other drugs received by patient: MST / 00036302 /; Novalgin / 00169801 /; Rulid; Pantoprazole; Paspertin / 00041902 /; Acyclovir; Electrolytes NOS W / Macrogol 3350; Dipyrone INJ; Metoclopramide; Acyclovir
Possible Vincristine side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: 52 year old female
Reactions: Tumour Lysis Syndrome, Posterior Reversible Encephalopathy Syndrome, Insomnia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Daunorubicin HCL
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Daunorubicin HCL
Dosage: at 50% dosage
Dexamethasone
Indication: Premedication
Methylprednisolone Sodium Succinate
Indication: B Precursor Type Acute Leukaemia
Prednisone TAB
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Vincristine
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Other drugs received by patient: Ondansetron; Voriconazole; Morphine Sulfate; Morphine
Possible Vincristine side effects in female
Reported by a physician from Thailand on 2012-08-24
Patient: female, weighing 57.4 kg (126.3 pounds)
Reactions: Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Doxorubicin Hydrochloride
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Mabthera
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Prednisone TAB
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Vincristine
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Other drugs received by patient: Dexamethasone; Acetaminophen; Ondansetron; Metformin HCL; Ondansetron; Ondansetron; Atenolol; Simvastatin; Benadryl
Possible Vincristine side effects in 49 year old male
Reported by a physician from Norway on 2012-08-24
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Possible Vincristine side effects in 51 year old male
Reported by a physician from Germany on 2012-08-24
Patient: 51 year old male
Reactions: Progressive Multifocal Leukoencephalopathy
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Indication: HIV Infection
Doxorubicin HCL
Indication: HIV Infection
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Mabthera
Indication: non-Hodgkin's Lymphoma
Mabthera
Indication: HIV Infection
Prednisone
Indication: HIV Infection
Prednisone TAB
Indication: non-Hodgkin's Lymphoma
Vincristine
Indication: HIV Infection
Vincristine
Indication: non-Hodgkin's Lymphoma
Possible Vincristine side effects in female
Reported by a physician from Bulgaria on 2012-08-24
Patient: female, weighing 63.0 kg (138.6 pounds)
Reactions: Circulatory Collapse, Bone Marrow Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000 milligram
Indication: Multiple Myeloma
Start date: 2012-05-23
End date: 2012-05-25
Dexamethasone
Dosage: 40 milligram
Start date: 2012-06-02
End date: 2012-06-05
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Start date: 2012-05-23
End date: 2012-05-26
Dexamethasone
Dosage: 20 milligram
Start date: 2012-05-16
End date: 2012-05-19
Doxorubicin Hydrochloride
Dosage: 80 milligram
Indication: Multiple Myeloma
Start date: 2012-05-26
End date: 2012-05-26
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-30
End date: 2012-06-07
Vincristine
Dosage: 2 milligram
Indication: Multiple Myeloma
Start date: 2012-05-26
End date: 2012-06-02
Other drugs received by patient: Milgamma; Dopamine HCL; Nexium; Atropine; Sodium Carbonate; Lyrica; Uromithexane; Electrolyte Infusions; Sodium Bicarbonate; Probitor; Tevagrastim
Possible Vincristine side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-23
Patient: male
Reactions: Dystonia, Encephalopathy, Parkinsonism
Drug(s) suspected as cause:
Cisplatin
Cyclophosphamide
Etoposide
Ifosfamide
Vincristine
Possible Vincristine side effects in male
Reported by a physician from Germany on 2012-08-23
Patient: male, weighing 85.0 kg (187.0 pounds)
Reactions: Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Chemotherapy
Diuretics
Mabthera
Dosage: unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-07-28
End date: 2012-07-28
Prednisone TAB
Indication: Chemotherapy
Ramipril
Vincristine
Indication: Chemotherapy
Other drugs received by patient: Torsemide; Allopurinol; Allopurinol; Pantoprazole; Pantoprazole; Potassium Chloride; Metoprolol Tartrate; Potassium Chloride; Ramipril; Hydrochlorothiazide
Possible Vincristine side effects in female
Reported by a pharmacist from United States on 2012-08-23
Patient: female, weighing 9.1 kg (20.0 pounds)
Reactions: Extravasation, Crying, Infusion Site Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Other drugs received by patient: Lactulose; Zofran; Lidocain / Prilocaine; Miralax; Maxitrol
Possible Vincristine side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Neutrophil Count Decreased, Hypokalaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cisplatin
Dosage: 3.5 mg/kg/day over 6 hours on day 4
Start date: 2012-07-27
Cisplatin
Dosage: 3.5 mg/kg/day over 6 hours on day 4
Indication: Medulloblastoma
Start date: 2012-07-26
End date: 2012-07-26
Cisplatin
Dosage: 3.5 mg/kg/day over 6 hours on day 4
Start date: 2012-07-02
End date: 2012-07-02
Cyclophosphamide
Dosage: 60 mg/kg/day over 1 hour on day 5 and 6
Indication: Medulloblastoma
Start date: 2012-07-27
End date: 2012-07-28
Cyclophosphamide
Dosage: 60 mg/kg/day over 1 hour on day 5 and 6
Start date: 2012-07-03
End date: 2012-07-04
Etoposide
Dosage: 2.5 mg/kg/day on days 4,5 and 6
Start date: 2012-07-02
End date: 2012-07-04
Etoposide
Dosage: 2.5 mg/kg/day on days 4,5 and 6
Start date: 2012-07-29
Etoposide
Dosage: 2.5 mg/kg/day on days 4,5 and 6
Indication: Medulloblastoma
Start date: 2012-07-26
End date: 2012-07-28
Furosemide
Dosage: 5 mg, qd
Start date: 2012-07-28
End date: 2012-07-29
Isotretinoin
Dosage: 80 mg/m2/dose, bid on days 1-4
Administration route: Oral
Indication: Medulloblastoma
Start date: 2012-07-23
End date: 2012-07-27
Isotretinoin
Dosage: 80 mg/m2/dose, bid on days 1-4
Administration route: Oral
Start date: 2012-06-29
Vincristine
Dosage: 0.05 mg/kg/day on days 4 11 and 18
Start date: 2012-07-02
Vincristine
Dosage: 0.05 mg/kg/day on days 4 11 and 18
Indication: Medulloblastoma
Start date: 2012-07-23
Vincristine
Dosage: 0.05 mg/kg/day on days 4 11 and 18
Start date: 2012-07-27
Vorinostat
Dosage: 230 mg/m2/dose on days 1-4
Administration route: Oral
Start date: 2012-06-29
Vorinostat
Dosage: 230 mg/m2/dose on days 1-4
Administration route: Oral
Indication: Medulloblastoma
Start date: 2012-07-23
End date: 2012-07-25
Possible Vincristine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-23
Patient: male
Reactions: Congestive Cardiomyopathy, Systolic Dysfunction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-06-26
End date: 2012-06-26
Cyclophosphamide
Start date: 2012-07-10
End date: 2012-07-10
Cyclophosphamide
Start date: 2012-06-08
End date: 2012-06-08
Cyclophosphamide
Start date: 2012-06-11
End date: 2012-06-11
Doxorubicine Actavis
Start date: 2012-06-26
End date: 2012-06-29
Doxorubicine Actavis
Start date: 2012-06-11
End date: 2012-06-11
Doxorubicine Actavis
Start date: 2012-07-10
End date: 2012-07-10
Mabthera
Start date: 2012-06-11
End date: 2012-06-11
Mabthera
Start date: 2012-06-26
End date: 2012-06-26
Mabthera
Start date: 2012-06-28
End date: 2012-06-28
Mabthera
Start date: 2012-07-05
End date: 2012-07-05
Mabthera
Start date: 2012-07-10
End date: 2012-07-10
Nexium
Administration route: Oral
Prednisolone
Administration route: Oral
Start date: 2012-06-08
Vincristine
Start date: 2012-06-08
End date: 2012-06-08
Vincristine
Start date: 2012-06-11
End date: 2012-06-11
Vincristine
Start date: 2012-06-26
End date: 2012-06-26
Vincristine
Start date: 2012-07-10
End date: 2012-07-10
Other drugs received by patient: Etoposide; Cacit D3; Aspirin; Acetaminophen; Prednisone TAB; Acetaminophen W / Codeine; Alendronate Sodium / Cholecalciferol; Previscan; Methotrexate Sodium; Potassium Chloride
Possible Vincristine side effects in 17 year old male
Reported by a physician from Poland on 2012-08-23
Patient: 17 year old male
Reactions: Rhabdomyolysis, Disseminated Intravascular Coagulation, Pancytopenia, Pyrexia, Renal Failure, Neutropenia, Clostridial Infection, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cefepime
Doxorubicin Hydrochloride
Indication: Ewing's Sarcoma
Etoposide
Indication: Ewing's Sarcoma Metastatic
Ifosfamide
Indication: Ewing's Sarcoma Metastatic
Meropenem
Metronidazole
Netromycin
Vancocin Hydrochloride
Vincristine
Indication: Ewing's Sarcoma Metastatic
Other drugs received by patient: Fluconazole; Caspofungin Acetate
Possible Vincristine side effects in 49 year old male
Reported by a physician from Norway on 2012-08-23
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Septic Shock, Lung Infiltration
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Baxter 15 000 IE Lyofilisat TIL Injeksjonsv?ske / Infusjonsv?s
Cyclophosphamide
Cyclophosphamide
Doxorubicin Hydrochloride
Doxorubicin Hydrochloride
Etoposide
Etoposide
Prednisolone
Administration route: Oral
Procarbazine Hydrochloride
Administration route: Oral
Vincristine
Possible Vincristine side effects in 18 year old female
Reported by a physician from Slovenia on 2012-08-23
Patient: 18 year old female
Reactions: Pulmonary Haemorrhage, Gastrointestinal Haemorrhage, Injection Site Haemorrhage, Sepsis, Shock Haemorrhagic, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Staphylococcal Bacteraemia, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Heparin
Vincristine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Possible Vincristine side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate Sodium
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin
Possible Vincristine side effects in male
Reported by a physician from France on 2012-08-22
Patient: male
Reactions: Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Burkitt's Lymphoma
Start date: 2012-05-21
End date: 2012-05-23
Doxorubicin Hydrochloride
Indication: Burkitt's Lymphoma
Start date: 2012-05-21
End date: 2012-05-21
Levoleucovorin Calcium
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-21
End date: 2012-05-26
Mabthera
Indication: Burkitt's Lymphoma
Start date: 2012-05-19
End date: 2012-05-19
Methotrexate Disodium
Indication: Burkitt's Lymphoma
Start date: 2012-05-20
End date: 2012-05-20
Prednisone TAB
Administration route: Oral
Indication: Burkitt's Lymphoma
Start date: 2012-05-20
End date: 2012-05-25
Vincristine
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-20
End date: 2012-05-26
Other drugs received by patient: Valaciclovir HCL; Lyrica; Bactrim DS; Emend; Allopurinol; Cytarabine; Ondansetron Hydrochloride; Nexium; Calciparine
Possible Vincristine side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male
Reactions: Rectal Haemorrhage, Constipation, Cardiac Disorder, Hospitalisation, Granulocytopenia, Inappropriate Antidiuretic Hormone Secretion, Thrombocytopenia, Cardiac Failure Congestive, Pneumonia, Anaemia, Pancytopenia, Atrial Fibrillation, Febrile Neutropenia, Syncope, Embolism, Sepsis, Dehydration, Asthenia, Mantle Cell Lymphoma Recurrent, Leukopenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1
Indication: Mantle Cell Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Indication: Mantle Cell Lymphoma
Leukine
Dosage: on day 9-15; 250 mcg/m2/day
Indication: Mantle Cell Lymphoma
Leukine
Dosage: on day 9-15; 250 mcg/m2/day
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Dosage: on days 1-5
Indication: Mantle Cell Lymphoma
Prednisone TAB
Dosage: on days 1-5
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: on day 15; as infusion
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: on day 15; as infusion
Indication: Mantle Cell Lymphoma
Vincristine
Dosage: on day 1 (maximum dose: 2mg)
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: on day 1 (maximum dose: 2mg)
Indication: Mantle Cell Lymphoma
Possible Vincristine side effects in
Reported by a physician from United Kingdom on 2012-08-22
Patient:
Reactions: Cystitis Noninfective
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1222.5 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-24
End date: 2012-08-02
Doxorubicin HCL
Dosage: 81.5 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-24
End date: 2012-08-02
Prednisolone
Dosage: 100 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-24
End date: 2012-08-02
Rituximab
Dosage: 611.75 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-24
End date: 2012-08-02
Velcade
Dosage: 2.11 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-12
End date: 2012-08-09
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-24
End date: 2012-08-02
Possible Vincristine side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22
Patient:
Reactions: Off Label Use, Gastrointestinal Toxicity
Drug(s) suspected as cause:
Carboplatin
Dosage: 6 courses in high risk
Indication: Retinoblastoma
Cyclophosphamide
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Doxorubicin HCL
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Etoposide
Dosage: 6 courses in high risk
Indication: Retinoblastoma
Vincristine
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Other drugs received by patient: Neupogen
Page 1 Next >>
|